VTRS Q4 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.2B+3.7% YoY

Gross Profit

$1.1B34.1% margin

Operating Income

$272M8.5% margin

Net Income

$21M0.6% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$687M

Free Cash Flow

$613M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$31.3B

Total Liabilities

$19.4B

Stockholders' Equity

$11.9B

Cash & Equivalents

$476M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$3.1B	+3.7%
Gross Profit	$1.1B	$1.0B	+7.1%
Operating Income	$272M	$233M	+17.0%
Net Income	$21M	$51M	-60.0%